These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22348563)

  • 1. Serum levels of GRO-α are elevated in association with disease activity in patients with Behçet's disease.
    Kato Y; Yamamoto T
    Int J Dermatol; 2012 Mar; 51(3):286-9. PubMed ID: 22348563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
    Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
    Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
    Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
    Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
    Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines in Behçet's disease.
    Sayinalp N; Ozcebe OI; Ozdemir O; Haznedaroğlu IC; Dündar S; Kirazli S
    J Rheumatol; 1996 Feb; 23(2):321-2. PubMed ID: 8882039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
    Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
    J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.
    El-Asrar AM; Al-Obeidan SS; Kangave D; Geboes K; Opdenakker G; Van Damme J; Struyf S
    Immunobiology; 2011 Sep; 216(9):1004-9. PubMed ID: 21531038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum mannose-binding lectin levels are decreased in behcet's disease and associated with disease severity.
    Inanc N; Mumcu G; Birtas E; Elbir Y; Yavuz S; Ergun T; Fresko I; Direskeneli H
    J Rheumatol; 2005 Feb; 32(2):287-91. PubMed ID: 15693089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease.
    Canpolat F; Unver M; Eskioğlu F; Kösebalaban S; Durmazlar SP
    Int J Dermatol; 2006 Sep; 45(9):1053-6. PubMed ID: 16961545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine: an activity marker in Behçet's disease?
    Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
    J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
    Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
    Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
    Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
    Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
    Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
    Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.
    Furuse S; Fujii H; Kaburagi Y; Fujimoto M; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2003 Jul; 30(7):1524-8. PubMed ID: 12858452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction.
    Kawakami T; Ohashi S; Kawa Y; Takahama H; Ito M; Soma Y; Mizoguchi M
    Arch Dermatol; 2004 May; 140(5):570-4. PubMed ID: 15148101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum ferritin levels in active Behçet's disease.
    Odabas AR; Karakuzu A; Cetinkaya R; Selcuk Y; Keles S; Bilen H
    Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
    Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
    Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin-8 as a serologic marker of activity in Behçet's disease.
    Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N
    Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.